Descriptor English: | Silybin | ||||||
Descriptor Spanish: |
Silibina
| ||||||
Descriptor Portuguese: | Silibina | ||||||
Descriptor French: | Silibinine | ||||||
Entry term(s): |
2,3 Dehydrosilybin 2,3-Dehydrosilybin Alepa forte Alepa-forte Ardeyhepan Cefasilymarin Durasilymarin Hepa Merz Sil Hepa loges Hepa-Merz Sil Hepa-loges HepaBesch Hepar Pasc Hepar-Pasc Heparsyx Heplant Lagosa Legalon Forte Silibin Silibinin Silibinin A Silibinin B Silybin A Silybin B Silybinin |
||||||
Tree number(s): |
D03.383.663.283.266.450.268.777.500 D03.633.100.150.266.450.268.777.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077385 | ||||||
Scope note: | The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents, Phytogenic Protective Agents |
||||||
Registry Number: | 4RKY41TBTF | ||||||
CAS Type 1 Name: | 4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)- | ||||||
Public MeSH Note: | 2019; SILYBIN was indexed under SILYMARIN 2002-2018 |
||||||
History Note: | 2019 (2002) |
||||||
DeCS ID: | 57629 | ||||||
Unique ID: | D000077385 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/05/07 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Silybin
- Preferred
Ardeyhepan
- Narrower
Cefasilymarin
- Narrower
Durasilymarin
- Narrower
Hepa-loges
- Narrower
Hepa-Merz Sil
- Narrower
Silybin B
- Narrower
Alepa-forte
- Narrower
HepaBesch
- Narrower
Hepar-Pasc
- Narrower
Heparsyx
- Narrower
Lagosa
- Narrower
2,3-Dehydrosilybin
- Narrower
Legalon Forte
- Narrower
Silybin A
- Narrower
Heplant
- Narrower
Concept UI |
M0019880 |
Scope note | The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers. |
Preferred term | Silybin |
Entry term(s) |
Silibin Silibinin Silybinin |
Concept UI |
M0475693 |
Preferred term | Ardeyhepan |
Concept UI |
M0475694 |
Preferred term | Cefasilymarin |
Concept UI |
M0475695 |
Preferred term | Durasilymarin |
Concept UI |
M0475696 |
Preferred term | Hepa-loges |
Entry term(s) |
Hepa loges |
Concept UI |
M0475697 |
Preferred term | Hepa-Merz Sil |
Entry term(s) |
Hepa Merz Sil |
Concept UI |
M000629762 |
Preferred term | Silybin B |
Entry term(s) |
Silibinin B |
Concept UI |
M0475692 |
Preferred term | Alepa-forte |
Entry term(s) |
Alepa forte |
Concept UI |
M0475698 |
Preferred term | HepaBesch |
Concept UI |
M0475699 |
Preferred term | Hepar-Pasc |
Entry term(s) |
Hepar Pasc |
Concept UI |
M0475700 |
Preferred term | Heparsyx |
Concept UI |
M0475703 |
Preferred term | Lagosa |
Concept UI |
M0500595 |
Preferred term | 2,3-Dehydrosilybin |
Entry term(s) |
2,3 Dehydrosilybin |
Concept UI |
M0554692 |
Preferred term | Legalon Forte |
Concept UI |
M000629761 |
Preferred term | Silybin A |
Entry term(s) |
Silibinin A |
Concept UI |
M0475702 |
Preferred term | Heplant |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey